tradingkey.logo

Quest Diagnostics Inc

DGX
173.700USD
+0.170+0.10%
收盤 01/02, 16:00美東報價延遲15分鐘
19.28B總市值
20.16本益比TTM

Quest Diagnostics Inc

173.700
+0.170+0.10%

關於 Quest Diagnostics Inc 公司

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Quest Diagnostics Inc簡介

公司代碼DGX
公司名稱Quest Diagnostics Inc
上市日期Dec 17, 1996
CEODavis (James E)
員工數量45000
證券類型Ordinary Share
年結日Dec 17
公司地址500 Plaza Drive
城市SECAUCUS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編07094
電話19735202700
網址https://www.questdiagnostics.com/
公司代碼DGX
上市日期Dec 17, 1996
CEODavis (James E)

Quest Diagnostics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
45.61K
+2.71%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
--
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.40K
-4.25%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
+4.79%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.04K
-6.84%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
11.85K
+11.30%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
10.25K
+0.15%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
6.46K
+22.86%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
2.70K
+0.22%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
45.61K
+2.71%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
--
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.40K
-4.25%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
+4.79%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.04K
-6.84%

收入明細

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
0.00
0.00%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.77%
T. Rowe Price Associates, Inc.
6.15%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.70%
Boston Partners
3.63%
其他
67.25%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.77%
T. Rowe Price Associates, Inc.
6.15%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.70%
Boston Partners
3.63%
其他
67.25%
股東類型
持股股東
佔比
Investment Advisor
55.48%
Investment Advisor/Hedge Fund
32.65%
Research Firm
4.36%
Pension Fund
2.24%
Bank and Trust
1.67%
Hedge Fund
1.52%
Sovereign Wealth Fund
1.23%
Individual Investor
0.44%
Insurance Company
0.11%
其他
0.30%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1802
110.45M
99.29%
-4.04M
2025Q3
1807
110.10M
100.22%
-700.93K
2025Q2
1819
110.85M
98.75%
+3.78M
2025Q1
1805
107.66M
97.04%
-1.03M
2024Q4
1782
103.84M
96.80%
+1.47M
2024Q3
1731
102.61M
95.91%
+134.75K
2024Q2
1739
102.41M
97.25%
-2.03M
2024Q1
1743
104.12M
95.50%
-1.89M
2023Q4
1768
101.63M
97.47%
-890.08K
2023Q3
1758
103.19M
98.04%
-229.61K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
14.20M
12.77%
+16.93K
+0.12%
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.84M
6.15%
-192.73K
-2.74%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
6.13M
5.51%
-81.33K
-1.31%
Sep 30, 2025
State Street Investment Management (US)
5.22M
4.7%
+38.93K
+0.75%
Sep 30, 2025
Boston Partners
4.04M
3.63%
+997.03K
+32.80%
Sep 30, 2025
JP Morgan Asset Management
3.77M
3.39%
+8.99K
+0.24%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.04M
2.73%
+54.07K
+1.81%
Sep 30, 2025
Victory Capital Management Inc.
2.34M
2.11%
-465.25K
-16.56%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.91M
1.71%
+6.16K
+0.32%
Sep 30, 2025
Wells Fargo Advisors
1.76M
1.59%
-30.59K
-1.70%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares U.S. Healthcare Providers ETF
3.1%
Madison Dividend Value ETF
2.17%
State Street SPDR S&P Health Care Services ETF
1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.81%
First Trust Total US Market AlphaDEX ETF
1.8%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Acruence Active Hedge US Equity ETF
1.26%
First Trust Health Care Alphadex Fund
1.21%
Timothy Plan High Dividend Stock ETF
1.19%
VictoryShares US Value Momentum ETF
1.01%
查看更多
iShares U.S. Healthcare Providers ETF
佔比3.1%
Madison Dividend Value ETF
佔比2.17%
State Street SPDR S&P Health Care Services ETF
佔比1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
佔比1.81%
First Trust Total US Market AlphaDEX ETF
佔比1.8%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.59%
Acruence Active Hedge US Equity ETF
佔比1.26%
First Trust Health Care Alphadex Fund
佔比1.21%
Timothy Plan High Dividend Stock ETF
佔比1.19%
VictoryShares US Value Momentum ETF
佔比1.01%

分紅派息

近5年累計派現 1.26B 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Nov 11, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jan 28, 2026 going ex on Jan 13, 2026
Jan 13, 2026
Jan 28, 2026
Jan 13, 2026
Aug 13, 2025
DGX.NB Final Cash Dividend of gross USD 0.8 paid on Oct 20, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Oct 20, 2025
Oct 03, 2025
May 14, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 21, 2025 going ex on Jul 07, 2025
Jul 07, 2025
Jul 21, 2025
Jul 07, 2025
Jan 30, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 21, 2025 going ex on Apr 07, 2025
Apr 07, 2025
Apr 21, 2025
Apr 07, 2025
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Aug 14, 2023
DGX.NB Final Cash Dividend of gross USD 0.71 paid on Oct 23, 2023 going ex on Oct 05, 2023 with reinvestment option
Oct 06, 2023
Oct 23, 2023
Oct 05, 2023
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Quest Diagnostics Inc的前五大股東是誰?

Quest Diagnostics Inc的前五大股東如下:
The Vanguard Group, Inc.
持有股份:14.20M
佔總股份比例:12.77%。
T. Rowe Price Associates, Inc.
持有股份:6.84M
佔總股份比例:6.15%。
BlackRock Institutional Trust Company, N.A.
持有股份:6.13M
佔總股份比例:5.51%。
State Street Investment Management (US)
持有股份:5.22M
佔總股份比例:4.70%。
Boston Partners
持有股份:4.04M
佔總股份比例:3.63%。

Quest Diagnostics Inc的前三大股東類型是什麼?

Quest Diagnostics Inc 的前三大股東類型分別是:
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.

有多少機構持有Quest Diagnostics Inc(DGX)的股份?

截至2025Q4,共有1802家機構持有Quest Diagnostics Inc的股份,合計持有的股份價值約為110.45M,占公司總股份的99.29% 。與2025Q3相比,機構持股有所增加,增幅為-0.93%。

哪個業務部門對Quest Diagnostics Inc的收入貢獻最大?

在FY2025Q3,--業務部門對Quest Diagnostics Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI